Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
LASE vs OESX vs ARAY vs NPKI vs ISRG
Revenue, margins, valuation, and 5-year total return — side by side.
Electrical Equipment & Parts
Medical - Devices
Oil & Gas Equipment & Services
Medical - Instruments & Supplies
LASE vs OESX vs ARAY vs NPKI vs ISRG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Electrical Equipment & Parts | Medical - Devices | Oil & Gas Equipment & Services | Medical - Instruments & Supplies |
| Market Cap | $16M | $33M | $35M | $1.30B | $161.07B |
| Revenue (TTM) | $7M | $81M | $429M | $287M | $10.58B |
| Net Income (TTM) | $-8M | $-5M | $-46M | $36M | $2.98B |
| Gross Margin | 31.1% | 29.9% | 26.8% | 35.2% | 66.3% |
| Operating Margin | -126.5% | -4.3% | -5.1% | 11.4% | 30.5% |
| Forward P/E | — | — | — | 29.3x | 43.8x |
| Total Debt | $5M | $10M | $176M | $37M | $303M |
| Cash & Equiv. | $534K | $6M | $57M | $5M | $3.37B |
LASE vs OESX vs ARAY vs NPKI vs ISRG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 24 | May 26 | Return |
|---|---|---|---|
| Laser Photonics Cor… (LASE) | 100 | 12.9 | -87.1% |
| Orion Energy System… (OESX) | 100 | 110.1 | +10.1% |
| Accuray Incorporated (ARAY) | 100 | 13.1 | -86.9% |
| NPK International I… (NPKI) | 100 | 184.6 | +84.6% |
| Intuitive Surgical,… (ISRG) | 100 | 83.7 | -16.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LASE vs OESX vs ARAY vs NPKI vs ISRG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LASE plays a supporting role in this comparison — it may shine differently against other peers.
OESX is the clearest fit if your priority is income & stability.
- Dividend streak 1 yrs, beta 1.10
Among these 5 stocks, ARAY doesn't own a clear edge in any measured category.
NPKI carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 27.4%, EPS growth 124.0%, 3Y rev CAGR 12.8%
- 27.4% revenue growth vs LASE's -13.3%
- Lower P/E (29.3x vs 43.8x)
- +94.9% vs ARAY's -78.4%
ISRG is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 5.5% 10Y total return vs NPKI's 91.5%
- Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
- Beta 1.02, current ratio 4.87x
- 28.2% margin vs LASE's -105.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 27.4% revenue growth vs LASE's -13.3% | |
| Value | Lower P/E (29.3x vs 43.8x) | |
| Quality / Margins | 28.2% margin vs LASE's -105.4% | |
| Stability / Safety | Beta 1.02 vs ARAY's 2.42, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +94.9% vs ARAY's -78.4% | |
| Efficiency (ROA) | 14.8% ROA vs LASE's -43.1%, ROIC 15.0% vs -42.1% |
LASE vs OESX vs ARAY vs NPKI vs ISRG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
LASE vs OESX vs ARAY vs NPKI vs ISRG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ISRG leads in 2 of 6 categories
ARAY leads 1 • NPKI leads 1 • LASE leads 1 • OESX leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ISRG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ISRG is the larger business by revenue, generating $10.6B annually — 1482.0x LASE's $7M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to LASE's -105.4%. On growth, LASE holds the edge at +28.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $7M | $81M | $429M | $287M | $10.6B |
| EBITDAEarnings before interest/tax | -$8M | -$1M | -$15M | $53M | $3.8B |
| Net IncomeAfter-tax profit | -$8M | -$5M | -$46M | $36M | $3.0B |
| Free Cash FlowCash after capex | -$4M | $348M | -$28M | $32M | $2.8B |
| Gross MarginGross profit ÷ Revenue | +31.1% | +29.9% | +26.8% | +35.2% | +66.3% |
| Operating MarginEBIT ÷ Revenue | -126.5% | -4.3% | -5.1% | +11.4% | +30.5% |
| Net MarginNet income ÷ Revenue | -105.4% | -5.6% | -10.8% | +12.4% | +28.2% |
| FCF MarginFCF ÷ Revenue | -58.7% | +4.3% | -6.5% | +11.1% | +26.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +28.3% | +7.7% | -7.4% | +15.9% | +23.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -7.4% | +109.6% | -6.1% | 0.0% | +18.8% |
Valuation Metrics
ARAY leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 36.8x trailing earnings, NPKI trades at a 36% valuation discount to ISRG's 57.6x P/E. On an enterprise value basis, ARAY's 11.0x EV/EBITDA is more attractive than ISRG's 43.6x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $16M | $33M | $35M | $1.3B | $161.1B |
| Enterprise ValueMkt cap + debt − cash | $21M | $37M | $154M | $1.3B | $158.0B |
| Trailing P/EPrice ÷ TTM EPS | -3.29x | -2.57x | -18.91x | 36.75x | 57.62x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 29.34x | 43.84x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 2.65x |
| EV / EBITDAEnterprise value multiple | — | — | 10.99x | 18.49x | 43.62x |
| Price / SalesMarket cap ÷ Revenue | 4.70x | 0.41x | 0.08x | 4.71x | 16.00x |
| Price / BookPrice ÷ Book value/share | 0.90x | 2.56x | 0.37x | 3.77x | 9.17x |
| Price / FCFMarket cap ÷ FCF | — | 66.51x | — | 49.58x | 64.67x |
Profitability & Efficiency
ISRG leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-184 for LASE. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARAY's 2.17x. On the Piotroski fundamental quality scale (0–9), NPKI scores 7/9 vs LASE's 1/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -183.5% | -0.0% | -77.5% | +10.3% | +16.9% |
| ROA (TTM)Return on assets | -43.1% | -0.0% | -10.1% | +8.5% | +14.8% |
| ROICReturn on invested capital | -42.1% | -34.8% | +3.0% | +9.9% | +15.0% |
| ROCEReturn on capital employed | -45.9% | -34.9% | +2.8% | +12.7% | +16.5% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 4 | 6 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.49x | 0.87x | 2.17x | 0.10x | 0.02x |
| Net DebtTotal debt minus cash | $4M | $4M | $119M | $31M | -$3.1B |
| Cash & Equiv.Liquid assets | $533,871 | $6M | $57M | $5M | $3.4B |
| Total DebtShort + long-term debt | $5M | $10M | $176M | $37M | $303M |
| Interest CoverageEBIT ÷ Interest expense | -6.60x | -3.29x | -1.86x | 77.08x | — |
Total Returns (Dividends Reinvested)
NPKI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NPKI five years ago would be worth $19,150 today (with dividends reinvested), compared to $606 for ARAY. Over the past 12 months, NPKI leads with a +94.9% total return vs ARAY's -78.4%. The 3-year compound annual growth rate (CAGR) favors NPKI at 24.2% vs ARAY's -56.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -63.8% | -38.0% | -65.5% | +27.6% | -19.3% |
| 1-Year ReturnPast 12 months | -74.1% | +31.2% | -78.4% | +94.9% | -15.4% |
| 3-Year ReturnCumulative with dividends | -76.6% | -38.7% | -91.8% | +91.5% | +49.6% |
| 5-Year ReturnCumulative with dividends | -72.0% | -83.6% | -93.9% | +91.5% | +58.7% |
| 10-Year ReturnCumulative with dividends | -72.0% | -32.5% | -94.5% | +91.5% | +554.2% |
| CAGR (3Y)Annualised 3-year return | -38.4% | -15.1% | -56.6% | +24.2% | +14.4% |
Risk & Volatility
Evenly matched — NPKI and ISRG each lead in 1 of 2 comparable metrics.
Risk & Volatility
ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than ARAY's 2.42 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NPKI currently trades 93.5% from its 52-week high vs LASE's 10.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.68x | 1.10x | 2.42x | 1.47x | 1.02x |
| 52-Week HighHighest price in past year | $6.77 | $18.64 | $2.10 | $16.50 | $603.88 |
| 52-Week LowLowest price in past year | $0.38 | $5.50 | $0.28 | $7.63 | $427.84 |
| % of 52W HighCurrent price vs 52-week peak | +10.7% | +49.6% | +14.0% | +93.5% | +75.1% |
| RSI (14)Momentum oscillator 0–100 | 38.5 | 41.8 | 58.4 | 56.6 | 42.4 |
| Avg Volume (50D)Average daily shares traded | 1.9M | 39K | 1.4M | 795K | 1.8M |
Analyst Outlook
LASE leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: NPKI as "Buy", ISRG as "Buy".
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | — | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | — | — | $622.60 |
| # AnalystsCovering analysts | — | — | — | 3 | 55 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | 2 | 1 | — | 0 | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.0% | 0.0% | +1.7% | +1.4% |
ISRG leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARAY leads in 1 (Valuation Metrics). 1 tied.
LASE vs OESX vs ARAY vs NPKI vs ISRG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is LASE or OESX or ARAY or NPKI or ISRG a better buy right now?
For growth investors, NPK International Inc.
(NPKI) is the stronger pick with 27. 4% revenue growth year-over-year, versus -13. 3% for Laser Photonics Corporation (LASE). NPK International Inc. (NPKI) offers the better valuation at 36. 8x trailing P/E (29. 3x forward), making it the more compelling value choice. Analysts rate NPK International Inc. (NPKI) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — LASE or OESX or ARAY or NPKI or ISRG?
On trailing P/E, NPK International Inc.
(NPKI) is the cheapest at 36. 8x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, NPK International Inc. is actually cheaper at 29. 3x.
03Which is the better long-term investment — LASE or OESX or ARAY or NPKI or ISRG?
Over the past 5 years, NPK International Inc.
(NPKI) delivered a total return of +91. 5%, compared to -93. 9% for Accuray Incorporated (ARAY). Over 10 years, the gap is even starker: ISRG returned +554. 2% versus ARAY's -94. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — LASE or OESX or ARAY or NPKI or ISRG?
By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.
(ISRG) is the lower-risk stock at 1. 02β versus Accuray Incorporated's 2. 42β — meaning ARAY is approximately 138% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 2% for Accuray Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — LASE or OESX or ARAY or NPKI or ISRG?
By revenue growth (latest reported year), NPK International Inc.
(NPKI) is pulling ahead at 27. 4% versus -13. 3% for Laser Photonics Corporation (LASE). On earnings-per-share growth, the picture is similar: NPK International Inc. grew EPS 124. 0% year-over-year, compared to 0. 0% for Orion Energy Systems, Inc.. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — LASE or OESX or ARAY or NPKI or ISRG?
Intuitive Surgical, Inc.
(ISRG) is the more profitable company, earning 28. 4% net margin versus -73. 8% for Laser Photonics Corporation — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -189. 3% for LASE. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is LASE or OESX or ARAY or NPKI or ISRG more undervalued right now?
On forward earnings alone, NPK International Inc.
(NPKI) trades at 29. 3x forward P/E versus 43. 8x for Intuitive Surgical, Inc. — 14. 5x cheaper on a one-year earnings basis.
08Which pays a better dividend — LASE or OESX or ARAY or NPKI or ISRG?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is LASE or OESX or ARAY or NPKI or ISRG better for a retirement portfolio?
For long-horizon retirement investors, Intuitive Surgical, Inc.
(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +554. 2% 10Y return). Accuray Incorporated (ARAY) carries a higher beta of 2. 42 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +554. 2%, ARAY: -94. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between LASE and OESX and ARAY and NPKI and ISRG?
These companies operate in different sectors (LASE (Industrials) and OESX (Industrials) and ARAY (Healthcare) and NPKI (Energy) and ISRG (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: LASE is a small-cap quality compounder stock; OESX is a small-cap quality compounder stock; ARAY is a small-cap quality compounder stock; NPKI is a small-cap high-growth stock; ISRG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.